Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, today announced that Stefan Weber, CEO, will present at the H.C. Wainwright Annual Healthcare Conference in New York, NY, on Wednesday, September 05, 2018 at 5:30 p.m. ET.
August 28, 2018
· 1 min read